{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T09:24:13Z","timestamp":1775208253036,"version":"3.50.1"},"reference-count":41,"publisher":"Consilium Medicum","issue":"4","license":[{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Terapevticheskii arkhiv"],"abstract":"<jats:p>Analysis of routine clinical practice of hypertensive patient management represents one of the important tools in the search for further ways to minimize hypertension-associated cardiovascular and renal adverse outcomes. Aim. To compare the strategies for hypertension management and features of clinical use of I1-imidazoline receptor (I1-IR) agonists in the Russian Federation and other countries where the STRAIGHT (Selective imidazoline receptor agonists Treatment Recommendation and Action In Global management of HyperTension) study was conducted. Materials and methods. It was a cross-sectional online study involving physicians of various specializations. The study was conducted from January 18 to July 1, 2019, in seven countries with a high rate of I1-IR agonist prescription, including Russia. Results. A total of 125 (4.5%) responders filled out the survey in the Russian Federation, which was somewhat lower than in other countries (6.8%). The participants were mostly general practitioners (54.0%) and cardiologists (42.0%), while in other countries greater diversity was seen. Most Russian physicians (83.0%) seemed to rely on national clinical guidelines in their routine practice, while in other countries the US guidelines were more popular (66.0%). The majority of responders stated that they took into account the traditional risk factors of hypertension when initiating the therapy; every second responder noted if sleep apnea was present. Awareness of I1-IR agonists, their prescription rate and their preference were higher in Russia. The main reported benefits of I1-IR agonists were their efficacy, including in resistant hypertension, and their metabolic effects (in Russia). Most participants preferred I1-IR agonists as third-line therapy (65.0% in Russia vs 60.0% in other countries) and in combination with an angiotensin-converting enzyme inhibitor (ACEi) or angiotensin II receptor blockers (ARB) (55.0% in Russia vs 54.0% in other countries). Compared to responders from other countries, Russian physicians prescribe I1-IR agonists as first-line (15.0% vs 5.0%) and second-line (48.0% vs 21.0%) therapy more often. Conclusion. Russian physicians were the most aware of I1-IR agonists and tended to prescribe drugs of this class for hypertension management more often, and I1-IR agonist combination with ACEi was preferable compared to physician responders from other countries. Antihypertensive efficacy and metabolic effects were reported as the major benefits of I1-IR agonist therapy.<\/jats:p>","DOI":"10.26442\/00403660.2021.04.200818","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T14:24:03Z","timestamp":1624458243000},"page":"440-448","source":"Crossref","is-referenced-by-count":7,"title":["Features of antihypertensive therapy and real-world prescription of selective imidazoline receptor agonists in Russia vs other countries: STRAIGHT study data analysis"],"prefix":"10.26442","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8169-7812","authenticated-orcid":false,"given":"Alexandra O.","family":"Konradi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6533-5950","authenticated-orcid":false,"given":"Nadezhda E.","family":"Zvartau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9822-4357","authenticated-orcid":false,"given":"Irina E.","family":"Chazova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7895-9068","authenticated-orcid":false,"given":"Juliya V.","family":"Zhernakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9217-4937","authenticated-orcid":false,"given":"Aletta E.","family":"Schutte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1765-0195","authenticated-orcid":false,"given":"Markus P.","family":"Schlaich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18344","published-online":{"date-parts":[[2021,4,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.15829\/1728-8800-2014-4-4-14"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233801"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.20996\/1819-6446-2019-15-4-450-466"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32008-2"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.gheart.2015.04.006"},{"key":"ref6","unstructured":"\u0410\u0440\u0442\u0435\u0440\u0438\u0430\u043b\u044c\u043d\u0430\u044f \u0433\u0438\u043f\u0435\u0440\u0442\u0435\u043d\u0437\u0438\u044f \u0443 \u0432\u0437\u0440\u043e\u0441\u043b\u044b\u0445. \u041a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0440\u0435\u043a\u043e\u043c\u0435\u043d\u0434\u0430\u0446\u0438\u0438. \u041c\u0438\u043d\u0438\u0441\u0442\u0435\u0440\u0441\u0442\u0432\u043e \u0437\u0434\u0440\u0430\u0432\u043e\u043e\u0445\u0440\u0430\u043d\u0435\u043d\u0438\u044f \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u043e\u0439 \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u0438, 2020. \u0420\u0435\u0436\u0438\u043c \u0434\u043e\u0441\u0442\u0443\u043f\u0430: https:\/\/sudact.ru\/law\/klinicheskie-rekomendatsii-arterialnaia-gipertenziia-u-vzroslykh-utv\/klinicheskie-rekomendatsii\/ C\u0441\u044b\u043b\u043a\u0430 \u0430\u043a\u0442\u0438\u0432\u043d\u0430 \u043d\u0430 10.04.2021 [Arterial\u2019naia gipertenziia u vzroslykh. Klinicheskie rekomendatsii. Ministerstvo zdravookhraneniia Rossiiskoi Federatsii, 2020. Available at: https:\/\/sudact.ru\/law\/klinicheskie-rekomendatsii-arterialnaia-gipertenziia-u-vzroslykh-utv\/klinicheskie-rekomendatsii\/ Accessed: 10.04.2021"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000001961"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.15829\/1560-4071-2020-3-3786"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.018912"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.114.302524"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.18705\/1607-419X-2015-21-5-450-458"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12553"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"\u0427\u0443\u0431\u0435\u043d\u043a\u043e \u0415.\u0410., \u0411\u0435\u043b\u044f\u0435\u0432\u0430 \u041e.\u0414., \u0411\u0430\u0436\u0435\u043d\u043e\u0432\u0430 \u0422.\u041b., \u0438 \u0434\u0440. \u041f\u043b\u0435\u0439\u043e\u0442\u0440\u043e\u043f\u043d\u044b\u0435 \u044d\u0444\u0444\u0435\u043a\u0442\u044b \u043c\u043e\u043a\u0441\u043e\u043d\u0438\u0434\u0438\u043d\u0430. \u0410\u0440\u0442\u0435\u0440\u0438\u0430\u043b\u044c\u043d\u0430\u044f \u0433\u0438\u043f\u0435\u0440\u0442\u0435\u043d\u0437\u0438\u044f. 2010;16(4):351-5 [Chubenko \u0415\u0410, Belyaeva \u041eD, Bazhenova \u0415\u0410, et al. Pleiotropic effects of moxonidine. Arterial\u2019naya Gipertenziya (Arterial Hypertension). 2010;16(4):351-5 (In Russ.)].","DOI":"10.18705\/1607-419X-2010-16-4-351-355"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"\u0421\u0440\u043e\u0436\u0438\u0434\u0438\u043d\u043e\u0432\u0430 \u041d.\u0417., \u0422\u0443\u0445\u0442\u0430\u0435\u0432 \u0410.\u0410. \u042d\u0444\u0444\u0435\u043a\u0442\u0438\u0432\u043d\u043e\u0441\u0442\u044c \u043c\u043e\u043a\u0441\u043e\u043d\u0438\u0434\u0438\u043d\u0430 \u0432 \u043b\u0435\u0447\u0435\u043d\u0438\u0438 \u0430\u0440\u0442\u0435\u0440\u0438\u0430\u043b\u044c\u043d\u043e\u0439 \u0433\u0438\u043f\u0435\u0440\u0442\u0435\u043d\u0437\u0438\u0438 \u0443 \u0431\u043e\u043b\u044c\u043d\u044b\u0445 \u0441 \u043c\u0435\u0442\u0430\u0431\u043e\u043b\u0438\u0447\u0435\u0441\u043a\u0438\u043c \u0441\u0438\u043d\u0434\u0440\u043e\u043c\u043e\u043c. \u0410\u0440\u0442\u0435\u0440\u0438\u0430\u043b\u044c\u043d\u0430\u044f \u0433\u0438\u043f\u0435\u0440\u0442\u0435\u043d\u0437\u0438\u044f. 2013;3(29): 42-7 [Srozhidinova NZ, Tukhtayev AA. Moxonidine efficiency in hypertension treatment in patients with metabolic syndrome. Arterial Hypertension. 2013;3(29):42-7 (In Russ.)].","DOI":"10.22141\/2224-1485.3.29.2013.86501"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.18087\/cardio.2508"},{"key":"ref16","unstructured":"\u0411\u0430\u0440\u0430\u043d\u043e\u0432\u0430 \u0415.\u0418., \u0411\u043e\u043b\u044c\u0448\u0430\u043a\u043e\u0432\u0430 \u041e.\u041e. \u041c\u0435\u0442\u0430\u0431\u043e\u043b\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0441\u0435\u0440\u0434\u0435\u0447\u043d\u043e-\u0441\u043e\u0441\u0443\u0434\u0438\u0441\u0442\u044b\u0439 \u0441\u0438\u043d\u0434\u0440\u043e\u043c \u0432 \u043f\u043e\u0441\u0442\u043c\u0435\u043d\u043e\u043f\u0430\u0443\u0437\u0435. \u0410\u0440\u0442\u0435\u0440\u0438\u0430\u043b\u044c\u043d\u0430\u044f \u0433\u0438\u043f\u0435\u0440\u0442\u0435\u043d\u0437\u0438\u044f. 2005;11(2):111-5 [Baranova YI, Bolshakova OO. Metabolic cardiovascular syndrome in postmenopause. Arterial\u2019naya Gipertenziya (Arterial Hypertension). 2005;11(2):111-5 (In Russ.)]."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001676"},{"key":"ref18","unstructured":"Sanjuliani AF, Genelhu-Fagunde V, Barroso SG, et al. Effect of imidazoline agonist on sympathetic activity and components of the insulin resistance syndrome in obese hypertensive Brasilian patients. J Hypertens. 2002;20:S206."},{"key":"ref19","unstructured":"Kaaja R, Manhem K, Tuomilehto J. Treatment of postmenopausal hypertension with moxonidine, a selective imidazoline receptor agonist. Int J Clin Pract. 2004;Suppl. 139:26-32."},{"key":"ref20","unstructured":"Haenni A, Lithell H. Moxonidine improves insulin sensitivity in insulin-resistant hypertensives. J Hypertens. 1999;17(Suppl. 3):S29-S35."},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Friedman JE, Ishizuka T, Liu S, et al. Anti-hyperglycemic activity of moxonidine: metabolic and molecular effects in obese spontaneously hypertensive rats. Blood Press Suppl. 1998;3:32-9.","DOI":"10.1080\/080370598438465"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/541689"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2006.00606.x"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.09305.x"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2006.00951.x"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2020.1835852"},{"key":"ref27","unstructured":"Boniol M, Mcisaac M, Xu L, et al. Campbell Gender equity in the health workforce: Analysis of 104 countries, 2019. Available at: http:\/\/apps.who.int\/bookorders. Accessed: 28.06.2020."},{"key":"ref28","unstructured":"\u0421\u0432\u0438\u0440\u044f\u0435\u0432 \u042e.\u0412., \u041a\u043e\u0440\u043e\u0441\u0442\u043e\u0432\u0446\u0435\u0432\u0430 \u041b.\u0421., \u0417\u0432\u0430\u0440\u0442\u0430\u0443 \u041d.\u042d., \u0438 \u0434\u0440. \u0421\u0438\u043d\u0434\u0440\u043e\u043c \u043e\u0431\u0441\u0442\u0440\u0443\u043a\u0442\u0438\u0432\u043d\u043e\u0433\u043e \u0430\u043f\u043d\u043e\u044d \u0432\u043e \u0441\u043d\u0435 \u043a\u0430\u043a \u043c\u0435\u0434\u0438\u043a\u043e-\u0441\u043e\u0446\u0438\u0430\u043b\u044c\u043d\u0430\u044f \u043f\u0440\u043e\u0431\u043b\u0435\u043c\u0430. \u0410\u0440\u0442\u0435\u0440\u0438\u0430\u043b\u044c\u043d\u0430\u044f \u0433\u0438\u043f\u0435\u0440\u0442\u0435\u043d\u0437\u0438\u044f. 2008;14(1-S2):127-34 [Sviryaev YV, Korostovtseva LS, Zvartau NE, et al. Obstructive Apnea Syndrome in Sleep as a Medico-Social Problem. Arterial\u2019naya Gipertenziya (Arterial Hypertension). 2008;14(1-S2):127-34 (In Russ.)]."},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.18705\/1607-419X-2012-18-3-184-190"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.26442\/2075082X.2019.1.190179"},{"key":"ref31","unstructured":"\u041f\u0440\u0438\u043a\u0430\u0437 \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438 \u043e\u0442 07.08.2013 N 549\u043d \u00ab\u041e\u0431 \u0443\u0442\u0432\u0435\u0440\u0436\u0434\u0435\u043d\u0438\u0438 \u0442\u0440\u0435\u0431\u043e\u0432\u0430\u043d\u0438\u0439 \u043a \u043a\u043e\u043c\u043f\u043b\u0435\u043a\u0442\u0430\u0446\u0438\u0438 \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u0435\u043d\u043d\u044b\u043c\u0438 \u043f\u0440\u0435\u043f\u0430\u0440\u0430\u0442\u0430\u043c\u0438 \u0438 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u043c\u0438 \u0438\u0437\u0434\u0435\u043b\u0438\u044f\u043c\u0438 \u0443\u043a\u043b\u0430\u0434\u043e\u043a \u0438 \u043d\u0430\u0431\u043e\u0440\u043e\u0432 \u0434\u043b\u044f \u043e\u043a\u0430\u0437\u0430\u043d\u0438\u044f \u0441\u043a\u043e\u0440\u043e\u0439 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u043e\u0439 \u043f\u043e\u043c\u043e\u0449\u0438\u00bb (\u0437\u0430\u0440\u0435\u0433\u0438\u0441\u0442\u0440\u0438\u0440\u043e\u0432\u0430\u043d\u043e \u0432 \u041c\u0438\u043d\u044e\u0441\u0442\u0435 \u0420\u043e\u0441\u0441\u0438\u0438 09.09.2013\/\u041a\u043e\u043d\u0441\u0443\u043b\u044c\u0442\u0430\u043d\u0442\u041f\u043b\u044e\u0441. \u0420\u0435\u0436\u0438\u043c \u0434\u043e\u0441\u0442\u0443\u043f\u0430: http:\/\/www.consultant.ru\/document\/cons_doc_LAW_151873. \u0421\u0441\u044b\u043b\u043a\u0430 \u0430\u043a\u0442\u0438\u0432\u043d\u0430 \u043d\u0430 10.04.2021 [Prikaz Minzdrava Rossii ot 07.08.2013 N 549n \u201cOb utverzhdenii trebovanii k komplektatsii lekarstvennymi preparatami i meditsinskimi izdeliiami ukladok i naborov dlia okazaniia skoroi meditsinskoi pomoshchi\u201d (zaregistrirovano v Miniuste Rossii 09.09.2013\/Konsul\u2019tantPlius. Available at: http:\/\/www.consultant.ru\/document\/cons_doc_LAW_151873. Accessed: 10.04.2021"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000597"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.18087\/cardio.2020.4.n1112"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199715011-00007"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199715010-00010"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-820915"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199424001-00005"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2010.6"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.18087\/rhj.2015.6.2145"},{"key":"ref40","unstructured":"\u041f\u0430\u043b\u0435\u0435\u0432 \u041d.\u0420., \u0428\u0443\u0433\u0430\u043d\u043e\u0432 \u0415.\u0413., \u0420\u0430\u0441\u043f\u043e\u043f\u0438\u043d\u0430 \u041d.\u0410., \u0412\u0438\u043b\u044c\u0447\u0438\u043d\u0441\u043a\u0430\u044f \u041d.\u0412. \u041c\u043e\u043a\u0441\u043e\u043d\u0438\u0434\u0438\u043d \u0432 \u043a\u043e\u043c\u0431\u0438\u043d\u0438\u0440\u043e\u0432\u0430\u043d\u043d\u044b\u0439 \u0442\u0435\u0440\u0430\u043f\u0438\u0438 \u0433\u0438\u043f\u0435\u0440\u0442\u043e\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u0431\u043e\u043b\u0435\u0437\u043d\u0438 \u0443 \u0431\u043e\u043b\u044c\u043d\u044b\u0445 \u0445\u0440\u043e\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u043e\u0431\u0441\u0442\u0440\u0443\u043a\u0442\u0438\u0432\u043d\u043e\u0439 \u0431\u043e\u043b\u0435\u0437\u043d\u044c\u044e \u043b\u0435\u0433\u043a\u0438\u0445. \u041a\u0430\u0440\u0434\u0438\u043e\u0432\u0430\u0441\u043a\u0443\u043b\u044f\u0440\u043d\u0430\u044f \u0442\u0435\u0440\u0430\u043f\u0438\u044f \u0438 \u043f\u0440\u043e\u0444\u0438\u043b\u0430\u043a\u0442\u0438\u043a\u0430. 2006;5(4):52-6 [Paleev NR, Shuganov EG, Raspopina NA, Vilchinskaja NV. Moxonidine in combined therapy of essential arterial hypertension patients with chronic obstructive pulmonary disease. Cardiovascular Therapy and Prevention. 2006;5(4):52-6. (In Russ.)]."},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"\u0428\u043b\u044f\u0445\u0442\u043e \u0415.\u0412., \u0417\u0432\u0430\u0440\u0442\u0430\u0443 \u041d.\u042d., \u0412\u0438\u043b\u043b\u0435\u0432\u0430\u043b\u044c\u0434\u0435 \u0421.\u0412., \u0438 \u0434\u0440. \u0421\u0438\u0441\u0442\u0435\u043c\u0430 \u0443\u043f\u0440\u0430\u0432\u043b\u0435\u043d\u0438\u044f \u0441\u0435\u0440\u0434\u0435\u0447\u043d\u043e-\u0441\u043e\u0441\u0443\u0434\u0438\u0441\u0442\u044b\u043c\u0438 \u0440\u0438\u0441\u043a\u0430\u043c\u0438: \u043f\u0440\u0435\u0434\u043f\u043e\u0441\u044b\u043b\u043a\u0438 \u043a \u0441\u043e\u0437\u0434\u0430\u043d\u0438\u044e, \u043f\u0440\u0438\u043d\u0446\u0438\u043f\u044b \u043e\u0440\u0433\u0430\u043d\u0438\u0437\u0430\u0446\u0438\u0438, \u0442\u0430\u0440\u0433\u0435\u0442\u043d\u044b\u0435 \u0433\u0440\u0443\u043f\u043f\u044b. \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u043a\u0430\u0440\u0434\u0438\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0436\u0443\u0440\u043d\u0430\u043b. 2019;24(11):69-82 [Shlyakhto EV, Zvartau NE, Villevalde SV, et al. Cardiovascular risk management system: prerequisites for developing, organization principles, target groups. Russian Journal of Cardiology. 2019;24(11):69-82 (In Russ.)].","DOI":"10.15829\/1560-4071-2019-11-69-82"}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"link":[{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/71226\/52025","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/71226\/52025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T08:17:21Z","timestamp":1672561041000},"score":1,"resource":{"primary":{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/view\/71226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,15]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,15]]}},"URL":"https:\/\/doi.org\/10.26442\/00403660.2021.04.200818","relation":{},"ISSN":["2309-5342","0040-3660"],"issn-type":[{"value":"2309-5342","type":"electronic"},{"value":"0040-3660","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,15]]}}}